SolarWinds Market Cap

HLB Pharmaceutical has a market cap or net worth of 211.34 billion as of August 8, 2025. Its market cap has decreased by -51.14% in one year.

Market Cap

211.34B

Enterprise Value

n/a

Revenue

36.10B

Ranking

n/a

PE Ratio

447.13

Stock Price

$15,050.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 211.34B, an increase of 150.75%. That is a compound annual growth rate of 10.01%.

Market Cap History

Date	Market Cap	% Change
Aug 7, 2025	216.95B	-35.89%
Dec 30, 2024	338.42B	58.45%
Dec 28, 2023	213.58B	43.49%
Dec 29, 2022	148.85B	-21.48%
Dec 30, 2021	189.57B	-21.05%
Dec 30, 2020	240.12B	219.34%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro
Dec 21, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.80T
Celltrion	39.20T
ALTEOGEN	23.73T
SK Biopharmaceuticals	8,724.10B
Yuhan	8,599.10B
Peptron	6,872.72B
HLB Co., Ltd.	6,237.58B
PharmaResearch	5,859.76B

Market Cap Rankings